Here’s what you should know.
1. The study examined the effects of the procedure in 63 patients. Patients either underwent the procedure with the EsophyX device or received high-dose proton-pump inhibitor therapy. After six months the PPI control group received the TIF procedure.
2. The study showed 83 percent of patients who underwent a TIF procedure eliminated regurgitation and all atypical symptoms. There were 70 percent of patients who discontinued PPI therapy and at the 36-month follow-up 87 percent saw healing of the reflux esophagitis.
More GI/endoscopy news:
FDA clears Pure-Vu System for intra-procedural colon cleaning: 3 notes
FDA approves STELARA for Crohn’s disease treatment: 5 notes
AGA objects to American Board of Internal Medicine’s certification proposals: 4 notes